Mural Health Enters Market to Disrupt Clinical Trial Participant Management with Launch of Mural Link Platform

Founders respond to participant needs to manage trial retention

BERWYN, Father., November 14, 2022 /PRNewswire/ — Mural Health Technologies, Inc., a new global provider of clinical trial technology, today announced the launch of its new technology platform, Mural Link, built to make it easy to become a participant in global clinical research to be studies. Among other planned participant-focused feature sets, Mural Link is excited to introduce the industry’s next-generation participant payment technology, designed by Sam Whitaker, the inventor of the industry’s first participant payment technology product, the ClinCard. Mural Link’s payment technology is complemented by three other initial features, namely transportation, two-way messaging and participant feedback, which will help participants overcome existing barriers to enrolling in and remaining in clinical trials.

In 2008, Sam Whitaker Founded Greenphire and invented the first participant payment technology, the ClinCard. Over the past 15 years, technologies have evolved and the world has changed how it functions. Since the ClinCard’s launch, there has been an undeniable shift towards the digitization of all aspects of daily life, including personal financial management, transport and communication. Individuals have also become increasingly empowered in their relationships with the parts of the healthcare ecosystem that they interact with in their daily lives. Unfortunately, although not surprisingly, clinical trial technology has not adapted to meet the needs of a developing world and contemporary clinical research participants.

To address the existing disparity, Sam and the Mural Health team built a platform that focuses all of its efforts on improving the patient experience and assisting participant populations that struggle to engage and remain in studies . Mural Link’s next-generation participant payment technology is being strategically leveraged by the platform to introduce and deliver other features that benefit both patients and their caregivers. All of the features of the Mural Link platform are designed to improve site-level operations and deliver greater strategic value to sponsors than that offered by point solutions that deliver payments via prepaid debit card. Mural Health’s platform will also offer unique structures to benefit other eClinical technologies and CROs.

“This time, I don’t think of the payment technology as the end goal, but rather as a strategic first step that will help Mural Health achieve a much larger product vision and consequently have a more profound impact on the global patient population.” Sam said. “We want to improve participants’ experience in trials. We want to make it easy to be part of a trial, so that more diverse populations can enroll and stay involved after randomization. We have a big vision and our entire team is passionate about the journey ahead.”

“Payments are important, but Mural Link is built to do much more than just deliver payment to participants. The platform also helps participants get to their appointment (transportation) without incurring costs, helps participants with communicate site staff (secure two-way in-app communication), and empowers the participant by giving them a voice, to provide feedback, which quantifies satisfaction with the participant’s trial trip.Mural Link is the first product that the sponsor satisfaction and will provide real-time retention data across all sites in a study. The platform will empower the study to identify at-risk participants to proactively correct issues and retain individuals who would otherwise drop out.”

Mural Health will launch its platform at the CNS Summit in Boca Raton, FL on November 17-20, 2022.

Feel free to contact us at [email protected] with any queries. Learn more about us on our new website:

About Mural Health Technologies, Inc.

Mural Health believes that a clinical trial cannot be successful if it does not take special care of its participants. Without the participants, critical data collection would not be possible. The aggregation of diverse human experience, around the world, is the underlying source of the datasets that drive progress in global drug development. Mural Health’s mission is to make participants’ lives easier and help bring together diverse lives, worldwide, to benefit global populations through more effective drug development.


Sophie Beattie
[email protected]

SOURCE Mural Health


Related Posts